Oct 01

SS 45 - GU 10: Biomarker Breakthroughs in Prostate Cancer

361 - Predictive Role of Tumor Fraction and Copy Number Alteration Burden in mCRPC Patients Receiving Tandem Actinium-Lutetium Radionuclide Therapy

11:10am - 11:20am PT

Presenter(s)

Mariam Amghar, MS - DKFZ/HIT/NCT/UKHD, Heidelberg,